类风湿关节炎中枢疼痛处理失调与改善病情抗风湿药治疗反应的相关性
高CPM失调者获得良好EULAR反应的比例显著低于低CPM失调者(22.5% vs 40.3%,P=0.01),校正后OR为0.40(95%CI 0.19-0.83)。
要点
- 高CPM失调与良好EULAR反应几率降低独立相关(OR 0.40,95%CI 0.19-0.83)。
- 时间总和与CPM同时失调者良好EULAR反应几率更低(OR 0.23,95%CI 0.07-0.73)。
- PPT和时间总和失调与良好EULAR反应呈相似趋势但未达统计学显著。
核心结论
- 低CPM(条件性疼痛调制)与获得良好EULAR反应几率降低显著相关,提示下行抑制机制效率不足可能是潜在治疗靶点。
主要发现
- 高CPM失调者良好EULAR反应比例为22.5%,低CPM失调者为40.3%(P=0.01)。
- 高中枢失调与良好EULAR反应的校正OR:PPT为0.59(95%CI 0.28-1.23),时间总和为0.60(95%CI 0.27-1.34),CPM为0.40(95%CI 0.19-0.83)。
- 时间总和与CPM同时失调者良好EULAR反应OR为0.23(95%CI 0.07-0.73)。
关键数值与推荐
- 治疗反应采用EULAR反应标准定义。
- 中枢失调通过定量感觉测试分类为高失调与低失调。
临床怎么用
- 对活动性RA患者,评估CPM等中枢疼痛处理指标可能有助于预判DMARD治疗反应。
- CPM失调者获得良好EULAR反应几率较低,提示需关注中枢疼痛机制并探索针对性干预。
局限性
- PPT和时间总和失调与治疗反应的关联未达统计学显著。
- 研究仅依据摘要信息,未报告其他潜在局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the association between dysregulated central pain processing and treatment response in rheumatoid arthritis (RA). METHODS: One hundred eighty-two participants with active RA were followed up for 12 weeks after starting a disease-modifying antirheumatic drug (DMARD). To assess central pain processing, participants underwent quantitative sensory testing (QST), including assessment of pressure pain thresholds (PPTs) at the trapezius muscles, temporal summation, and conditioned pain modulation (CPM). QST measures were categorized as high central dysregulation versus low central dysregulation. The association between baseline central dysregulation and treatment response, as defined by the European League Against Rheumatism (EULAR) response criteria, was assessed using multiple logistic regression adjusted for demographic characteristics, RA-related variables, and psychosocial variables. RESULTS: A good EULAR response was achieved in fewer participants with high CPM dysregulation than participants with low CPM dysregulation (22.5% versus 40.3%; P = 0.01). A similar trend, though not significant, was noted when central dysregulation was assessed with PPT and temporal summation. The adjusted odds ratios (ORs) for the association between high central dysregulation and good EULAR response were 0.59 for PPTs (95% confidence interval [95% CI] 0.28-1.23), 0.60 for temporal summation (95% CI 0.27-1.34), and 0.40 for CPM (95% CI 0.19-0.83). In a model examining the combined effects of dysregulated temporal summation and CPM, dysregulation of both measures was associated with lower odds of achieving a good EULAR response (OR 0.23 [95% CI 0.07-0.73]). CONCLUSION: Low CPM was significantly associated with lower odds of achieving a good EULAR response, suggesting that inefficient descending inhibitory mechanisms may be a potential treatment target for further study.
引用
- Heisler AC, Song J, Muhammad LN, et al. Association of Dysregulated Central Pain Processing and Response to Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis. Arthritis Rheumatol. 2020. PMID: 32683800. doi:10.1002/art.41440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。